The renoprotective effect of concomitant fosfomycin in the treatment of pulmonary exacerbations in cystic fibrosis.
Mohamed Al-AloulDilip S NazarethMartin WalshawPublished in: Clinical kidney journal (2019)
The addition of fosfomycin reduces acute renal injury caused by IV aminoglycoside therapy in CF pulmonary exacerbations.
Keyphrases
- cystic fibrosis
- pseudomonas aeruginosa
- pulmonary hypertension
- lung function
- chronic obstructive pulmonary disease
- liver failure
- urinary tract infection
- gram negative
- acinetobacter baumannii
- respiratory failure
- drug induced
- stem cells
- multidrug resistant
- intensive care unit
- combination therapy
- drug resistant
- mesenchymal stem cells
- replacement therapy
- smoking cessation
- air pollution
- cell therapy
- extracorporeal membrane oxygenation